Leonid Timashev
Stock Analyst at RBC Capital
(4.87)
# 329
Out of 4,587 analysts
467
Total ratings
58.7%
Success rate
22.6%
Average return
Main Sectors:
Stocks Rated by Leonid Timashev
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALKS Alkermes | Maintained: Buy | $56 | $48.34 | +15.85% | 22 | Jul 28, 2026 | |
| LEGN Legend Biotech | Reiterated: Buy | $63 → $59 | $18.85 | +213.00% | 45 | Jul 27, 2026 | |
| NUVB Nuvation Bio | Maintained: Buy | $19 | $6.59 | +188.32% | 12 | Jul 20, 2026 | |
| INSM Insmed | Maintained: Buy | $195 | $103.12 | +89.10% | 24 | Jul 16, 2026 | |
| PRAX Praxis Precision Medicines | Maintained: Buy | $449 | $291.03 | +54.28% | 2 | Jul 10, 2026 | |
| CRMD CorMedix | Maintained: Buy | $14 → $13 | $7.19 | +80.81% | 15 | Jul 7, 2026 | |
| CYTK Cytokinetics | Maintained: Buy | $119 → $117 | $78.39 | +49.26% | 22 | Jul 7, 2026 | |
| EXEL Exelixis | Maintained: Hold | $43 → $46 | $55.33 | -16.86% | 16 | Jul 7, 2026 | |
| JAZZ Jazz Pharmaceuticals | Maintained: Buy | $258 | $255.97 | +0.79% | 12 | Jul 7, 2026 | |
| VSTM Verastem | Maintained: Buy | $15 → $14 | $6.01 | +132.95% | 14 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $302 → $304 | $227.42 | +33.67% | 38 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $436 → $451 | $327.21 | +37.83% | 15 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $53 → $48 | $35.59 | +34.87% | 11 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 | $1.10 | +81.82% | 17 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $10.90 | +101.83% | 17 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $2.92 | +71.23% | 17 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $47 → $51 | $27.91 | +82.73% | 26 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $81 | $69.12 | +17.19% | 10 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $182 | $180.92 | +0.60% | 12 | Jun 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $13.43 | +63.81% | 30 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $48 → $59 | $39.75 | +48.43% | 39 | Jun 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $20 | $12.02 | +66.39% | 24 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 → $3 | $0.6001 | +399.92% | 7 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $2.87 | +387.80% | 9 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $19.53 | -2.71% | 7 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $5 | $3.86 | +29.53% | 4 | Apr 30, 2026 |
Alkermes
Jul 28, 2026
Maintained: Buy
Price Target: $56
Current: $48.34
Upside: +15.85%
Legend Biotech
Jul 27, 2026
Reiterated: Buy
Price Target: $63 → $59
Current: $18.85
Upside: +213.00%
Nuvation Bio
Jul 20, 2026
Maintained: Buy
Price Target: $19
Current: $6.59
Upside: +188.32%
Insmed
Jul 16, 2026
Maintained: Buy
Price Target: $195
Current: $103.12
Upside: +89.10%
Praxis Precision Medicines
Jul 10, 2026
Maintained: Buy
Price Target: $449
Current: $291.03
Upside: +54.28%
CorMedix
Jul 7, 2026
Maintained: Buy
Price Target: $14 → $13
Current: $7.19
Upside: +80.81%
Cytokinetics
Jul 7, 2026
Maintained: Buy
Price Target: $119 → $117
Current: $78.39
Upside: +49.26%
Exelixis
Jul 7, 2026
Maintained: Hold
Price Target: $43 → $46
Current: $55.33
Upside: -16.86%
Jazz Pharmaceuticals
Jul 7, 2026
Maintained: Buy
Price Target: $258
Current: $255.97
Upside: +0.79%
Verastem
Jul 7, 2026
Maintained: Buy
Price Target: $15 → $14
Current: $6.01
Upside: +132.95%
Jul 7, 2026
Maintained: Buy
Price Target: $302 → $304
Current: $227.42
Upside: +33.67%
Jul 7, 2026
Maintained: Buy
Price Target: $436 → $451
Current: $327.21
Upside: +37.83%
Jul 7, 2026
Maintained: Buy
Price Target: $53 → $48
Current: $35.59
Upside: +34.87%
Jul 7, 2026
Maintained: Hold
Price Target: $2
Current: $1.10
Upside: +81.82%
Jul 7, 2026
Maintained: Buy
Price Target: $22
Current: $10.90
Upside: +101.83%
Jul 7, 2026
Maintained: Buy
Price Target: $5
Current: $2.92
Upside: +71.23%
Jun 30, 2026
Maintained: Buy
Price Target: $47 → $51
Current: $27.91
Upside: +82.73%
Jun 30, 2026
Maintained: Buy
Price Target: $81
Current: $69.12
Upside: +17.19%
Jun 26, 2026
Maintained: Buy
Price Target: $182
Current: $180.92
Upside: +0.60%
Jun 25, 2026
Maintained: Buy
Price Target: $22
Current: $13.43
Upside: +63.81%
Jun 17, 2026
Rated: Buy
Price Target: $48 → $59
Current: $39.75
Upside: +48.43%
May 18, 2026
Maintained: Buy
Price Target: $14 → $20
Current: $12.02
Upside: +66.39%
May 14, 2026
Maintained: Hold
Price Target: $4 → $3
Current: $0.6001
Upside: +399.92%
May 11, 2026
Maintained: Buy
Price Target: $14
Current: $2.87
Upside: +387.80%
May 5, 2026
Maintained: Buy
Price Target: $19
Current: $19.53
Upside: -2.71%
Apr 30, 2026
Maintained: Hold
Price Target: $7 → $5
Current: $3.86
Upside: +29.53%